GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (OTCPK:EBOSF) » Definitions » Institutional Ownership

Ebos Group (Ebos Group) Institutional Ownership : 28.74% (As of Jun. 10, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Ebos Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Ebos Group's institutional ownership is 28.74%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Ebos Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Ebos Group's Float Percentage Of Total Shares Outstanding is 0.00%.


Ebos Group Institutional Ownership Historical Data

The historical data trend for Ebos Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Institutional Ownership Chart

Ebos Group Historical Data

The historical data trend for Ebos Group can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 29.05 29.75 29.52 29.30 29.21 29.23 28.85 28.96 28.97 28.74

Ebos Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Ebos Group (Ebos Group) Business Description

Traded in Other Exchanges
Address
108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024
Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (Ebos Group) Headlines

From GuruFocus

Half Year 2024 EBOS Group Ltd Earnings Call Transcript

By GuruFocus Research 02-28-2024